Schedule 13D ownership disclosure
PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23
Security class unavailable · CUSIP: 72942A107
Event date: 2020-05-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,473,218
- Percent of class
- 16.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-20-000473
- Form type
- SC 13D
- Filer
- PLx Pharma Inc.
- CIK
- CIK 1497504
- Filed
- May 20, 2020
- Reporting period
- May 15, 2020
- Description
- Schedule 13D beneficial ownership